MEDIROM Healthcare Technologies Inc.
MRM | undefined
-
At close: undefined
-
After-hours:
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 49.31M | 138.19M | -111.71M | 115.4M | -24.56M | 239.74M | -325.25M | -495.37M | -308.98M | -269.59M | -258.2M |
Depreciation & Amortization | 338.75M | 290.04M | 347.85M | 252.6M | 194.49M | 138.85M | 88.52M | 63.12M | 34.41M | 31.14M | 39.93M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | 23.96M | 98.43M | 74.47M | n/a | n/a |
Other Working Capital | -821.63M | -1.06B | -200.77M | 42.35M | 198.1M | 133.92M | 137.06M | 73.98M | 123.03M | 40.21M | -45.57M |
Other Non-Cash Items | -1.24B | -1.62B | -1.63B | -1.45B | -846.05M | -710.47M | -232.25M | -280.17M | -311.35M | -263.27M | -139.49M |
Deferred Income Tax | -188.71M | -188.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 149.67M | 1.97M | 595.01M | 498.76M | -269.06M | -146.45M | 100.87M | 54.25M | 156.91M | 133.56M | -101.46M |
Operating Cash Flow | -887.98M | -1.38B | -803.53M | -582.25M | -945.18M | -478.34M | -344.15M | -559.73M | -354.55M | -368.15M | -459.22M |
Capital Expenditures | -562.14M | -564.81M | -98.29M | -135.84M | -136.62M | -100.56M | -47.32M | -47.83M | -22.06M | -36.78M | -42.81M |
Cash Acquisitions | 1.09B | 893.1M | 7.69M | 4M | 6.34M | -69.99M | -111.46M | -187.88M | -178.82M | -49.6M | -21.2M |
Purchase of Investments | -5.66M | -5.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 29.56M | 29.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.26B | -433.88M | 409.39M | -172.53M | 782.86M | 718.03M | 595.57M | 164.59M | -304M | -24.51M | 29.3M |
Investing Cash Flow | -438.95M | 405.68M | 311.09M | -308.37M | 646.25M | 543.47M | 436.79M | -71.12M | -504.88M | -110.89M | -34.71M |
Debt Repayment | 463M | 324.96M | 295.89M | 286.09M | 323.43M | 269.75M | -202.86M | -252.26M | 15.37M | 389.47M | -28M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -108.1M | -5.04M | 103.06M | 140 | n/a | 43.7M | 43.42M | -2.87M | -7.07M | -105.3M | -320.54M |
Financial Cash Flow | 1.22B | 1.2B | 560.88M | 439.46M | 323.43M | 313.45M | -158.69M | -427.7M | 931.17M | 1.34B | 310.15M |
Net Cash Flow | -84.96M | 208.08M | 14.91M | -553.78M | -45.06M | 163.84M | -334.12M | -1.19B | 31.6M | 1.45B | 610.28M |
Free Cash Flow | -1.45B | -1.9B | -905.71M | -767.58M | -1.15B | -643.06M | -295M | -326.44M | -191.97M | -219.99M | -403.93M |
Adj. Free Cash Flow | -1.45B | -1.9B | -905.71M | -767.58M | -1.15B | -643.06M | -318.95M | -424.87M | -266.44M | -219.99M | -403.93M |
Maintenance CapEx | -130.15M | -114.13M | -79.6M | -99.78M | -20.18M | -20.18M | -20.18M | -35.4M | -42.81M | -42.81M | -42.81M |
Growth CapEx | -530.28M | -586.52M | -155.31M | -136.62M | -163.76M | -128.2M | -49.2M | -49.2M | -22.06M | -1.38M | n/a |
Owner Earnings | -1.83B | -2.08B | -1.9B | -1.27B | -1.28B | -841.3M | -437.77M | -497.23M | -573.84M | -218.15M | -131.59M |
Add to Watchlist
Select watchlists to add or remove MRM